The constitutive photomorphogenesis 9 (COP9) signalosome (CSN) plays key roles in many biological processes, such as repression of photomorphogenesis in plants and protein subcellular localization, DNA-damage response, and NF-κB activation in mammals. It is an evolutionarily conserved eight-protein complex with subunits CSN1 to CSN8 named following the descending order of molecular weights. Here, we report the crystal structure of the largest CSN subunit, CSN1 from Arabidopsis thaliana (atCSN1), which belongs to the Proteasome, COP9 signalosome, Initiation factor 3 (PCI) domain containing CSN subunit family, at 2.7 Å resolution. In contrast to previous predictions and distinct from the PCI-containing 26S proteasome regulatory particle subunit Rpn6 structure, the atCSN1 structure reveals an overall globular fold, with four domains consisting of helical repeat-I, linker helix, helical repeat-II, and the C-terminal PCI domain. Our small-angle X-ray scattering envelope of the CSN1-CSN7 complex agrees with the EM structure of the CSN alone (apo-CSN) and suggests that the PCI end of each molecule may mediate the interaction. Fitting of the CSN1 structure into the CSN-Skp1-Cul1-Fbox (SCF) EM structure shows that the PCI domain of CSN1 situates at the hub of the CSN for interaction with several other subunits whereas the linker helix and helical repeat-II of CSN1 contacts SCF using a conserved surface patch. Furthermore, we show that, in human, the C-terminal tail of CSN1, a segment not included in our crystal structure, interacts with IκBα in the NF-κB pathway. Therefore, the CSN complex uses multiple mechanisms to hinder NF-κB activation, a principle likely to hold true for its regulation of many other targets and pathways.
T he constitutive photomorphogenesis 9 (COP9) signalosome (CSN) is a more than 300-kDa complex that was first identified as a negative regulator of Constitutive Photomorphogenesis (COP) in plants (1, 2) . In the subsequent years, the highly conserved protein complex was also found in fungi (3, 4) , Caenorhabditis elegans (5), Drosophila melanogaster (6), and mammals (7, 8) . The most studied function of the CSN complex in eukaryotes is the regulation of protein degradation through two pathways, deneddylation (9) (10) (11) and deubiquitination (12, 13) . In the deneddylation pathway, the CSN complex can influence the cullin-RING ligase activity by removing Nedd8, a ubiquitin-like protein, from a cullin (9, 14) . On the other hand, the CSN complex can also suppress cullin activity through recruitment of the deubiquitination enzyme USP15 (12) or Ubp12p, the Schizosaccharomyces pombe ortholog of human USP15 (13) . Other functions of the CSN complex identified in mammalian cells include regulating the phosphorylation of ubiquitin-proteasome pathway substrates through CSN-associated kinases (7, (15) (16) (17) (18) . Overall, the CSN complex appears to be a key player in protein subcellular localization (19, 20) , DNA-damage response (21) , NF-κB activation (22) , development, and cell cycle control (23, 24) . Thus, the functions of the CSN complex are beyond the regulation of light-dependent reaction in plants.
The CSN complex in most of the species contains eight subunits named CSN1 to CSN8, in order of decreasing size. All eight subunits share homologous sequences with "lid" components of the 26S proteasome regulatory particle and the eukaryotic translation initiation factor 3 (eIF3) (7, 25) . Among these eight subunits, CSN6 and catalytic CSN5 contain a conserved MPNdomain (MOV34, Pad1N-terminal) (26) , and the rest of the CSN subunits bear a PCI-domain (Proteasome, COP9 signalosome, Initiation factor eIF3). The MPN-domain within CSN5 contains a metal chelating site and forms the catalytic region of the isopeptidase for deneddylation (27) . Recently, the crystal structures of the CSN6-MPN domain and the CSN5 subunit have been revealed (28, 29) . Interestingly, amino acids 97-131, a flexible segment within the CSN5-MPN domain, were proven to be essential in regulating the isopeptidase states of CSN5 (29) . PCI is an ∼200-amino acid domain, beginning with an N-terminal helical bundle arrangement and ending with a globular winged-helix subdomain (30, 31) . A number of interactions between PCI domains of CSN subunits have been identified by the yeast twohybrid system (32, 33) . Dessau et al. reported the crystallographic data of the PCI domain of Arabidopsis thaliana subunit 7, and their in vitro studies also suggested that the PCI domain mediates and stabilizes protein-protein interactions within the complex (34) .
Although many speculated on how the CSN subunits interact with each other and come into a functional unit, the architecture of the CSN complex was accessed by electron microscopy (EM) (35, 36) and native mass spectrometry approaches (37) . These studies confirmed structural similarities among CSN, the proteasome lid, and eIF3. Furthermore, the CSN appears to contain two dominant subcomplexes, CSN1/2/3/8 and CSN 4/5/6/7 (37), which correspond to the large and the small segments, respectively, in an EM study of the CSN alone (apo-CSN) (36) . An EM study of the CSN in complex with an Skp1-Cul1-Fbox (SCF) E3 ligase was also reported, showing reciprocal regulation between CSN and SCF (38) . To date, unfortunately, there is no high-resolution mapping on these subunit interactions.
To further define the CSN structure and to study its functional significance, we feel the need to obtain structures of CSN subunits at an atomic level. In our study, we used Arabidopsis thaliana CSN1 (atCSN1) as a guide to facilitate our understandings of the PCIcontaining CSN subunits. The atCSN1, encoded in the chromosome 3, has 441 amino acids that are 45% identical in sequence to Homo sapiens CSN1. Among all of the subunits of the complex, CSN1 is known to be the longest and to play a crucial role in complex integrity (39) (40) (41) . Here, we report the crystal structure of atCSN1 and describe its integration within the complex as well as its interaction with IκBα in the NF-κB signaling pathway.
Results and Discussion
Crystallization and Structure Determination. Full-length atCSN1 was first expressed in Escherichia coli BL21 (DE3), but the protein showed partial degradation. Therefore, we performed limited proteolysis on the full-length atCSN1 to identify a stable core fragment. Two Subtilisin-resistant fragments, atCSN1 (16-400 aa) and atCSN1 (16-380 aa), identified through mass spectrometry analysis and N-terminal sequencing, appeared to be candidates for downstream crystallization experiments (Fig. S1 ). CSN1) . Dash line represents a deletion in the sequence relative to atCSN1. Sequence insertions relative to atCSN1 are in light gray and are labeled with the species names. Strictly conserved residues among the 10 CSN1s are shown in white with a red background; other conserved residues among CSN1s are in red. The secondary structures of atCSN1 HR-I, LH, and HR-II are all presented in gray color whereas HB is in yellow and atCSN1 WH is in deep-teal green. Conserved surface residues within the LH and HR-II, which are possibly involved in SCF interaction, are indicated using gray circles. In addition, the secondary structures of Rpn6 (PDB ID code 3TXM) and atCSN7 (PDB ID code 3CHM) are compared with the secondary structure of atCSN1 side by side (34, 43) . Rpn6 HB is in yellow, and Rpn6 WH is in red. atCSN7 HB is also in yellow, and atCSN7 WH is in slate blue. Identical residues between atCSN1 and Rpn6 are shown in white with a magenta background. Identical residues between atCSN1 and atCSN7 are shown in black with a cyan background.
We were able to acquire crystals from the atCSN1 (16-400aa) construct, and the crystal structure was solved by multiwavelength anomalous diffraction at 3.5 Å resolution using crystals derivatized with the [Ta 6 Br 12 ]
2+ cluster (Table S1 ). The final atomic model was refined to 2.7 Å resolution. It contains four atCSN1 molecules, chain A (residues 32-349), chain B (residues 36-379), chain C (residues 32-352), and chain D (residues 32-379) (Fig. 1A) .
Structure Overview. The crystal structure of atCSN1 consists of two helical repeat domains (HR-I and HR-II), a linker helix (LH), and a PCI domain (PCID) (Fig. 1B) . HR-I and HR-II are tandem arrays of two and three helix-turn-helix units respectively. The helix-turn-helix unit is structurally similar to tetratricopeptide repeat (TPR) except that canonical TPR has 34 amino acids within each helix-turn-helix unit (42) . Canonical TPR is identified in a wide variety of proteins and usually functions as a protein-protein interaction module (42) . LH is the longest single α-helix within the protein, and it serves to join together HR-I and HR-II. Similar to other known PCID structures, the PCID of atCSN1 can be divided into two subdomains, helix bundle (HB) subdomain and winged-helix (WH) subdomain (30, 34) . The overall shape of atCSN1 is like the clubhead of a golf iron with approximate dimensions of 75 Å × 57 Å × 25 Å.
Because the proteasomal lid subunit Rpn6 from D. melanogaster (PDB id code 3TXM) shares homologous sequences and PCID with atCSN1 ( Fig. 2) , we compare the tertiary structures between the two molecules to better understand atCSN1 (Fig. 3A) . In Rpn6, the α-helical repeats, including a part of the PCID, form a right-handed suprahelical turn (43) . The suprahelical fold provides a convex surface for binding of the Rpt6, a "base" subunit of the 26S proteasome regulatory particle. In atCSN1, the lengths of the non-PCID helices (H1-H12) are less uniform than the ones in Rpn6 (Fig. 2) . Instead of forming an elongated suprahelical structure, the non-PCID helices in atCSN1 emerge into three distinct domains, which closely associate with each other. Meanwhile, the PCID coordinates with both HR-I and HR-II on the other side the molecule. These structural features lead to the formation of an overall compact, globular atCSN1 structure, in contrast to the more extended structure of Rpn6.
PCI Domain of atCSN1. When we put the PCI domains of Rpn6, atCSN7 (34) , and atCSN1 side by side, we observe similarities and differences among the three (Fig. 3 A and B) . The N-terminal boundary of Rpn6 PCID is different from those of atCSN1 and atCSN7 (31) , resulting in four helices in the HB domain of Rpn6 PCID and six helices in atCSN1 and atCSN7 (Fig. 2) . Whereas Rpn6 WH and atCSN7 WH are well aligned with each other (Fig. 3C) , a major structural discrepancy can be observed from atCSN1 WH. Helices H20 and H21, as a unit, orient differently in comparison with their counterpart helices in Rpn6 and atCSN7 (Fig. 3) . In our atCSN1 crystal structure, we can only visualize a partial WH subdomain, which lacks the last two β-strands (Figs. 2 and 3A) . One possibility is that the last two β-strands are not folded as stably as the rest of the atCSN1 structure, as shown by their protease sensitivity (Fig. S1 ). This instability may be due to the fact that the atCSN1 subunit was crystallized in isolation, rather than in the full CSN complex.
We also contemplated the possibility that the extensive crystal packing around the C-terminal region of the atCSN1 structure (Fig. S2 ) might have affected the local conformation. Because all known PCI-domain structures share the same fold as in atCSN7 and Rpn6, we attempted to model an alternative and a more complete PCI domain of atCSN1 as a potential conformation within the CSN complex. We first kept all of the current atCSN1 coordinates and added the βB and βC strands of Rpn6 by superimposing Rpn6 α17-α18 onto atCSN1 H20-H21. However, the modeled β-sheet crashes into the atCSN1 WH subdomain (Fig. S3A) . In both Rpn6 and atCSN7 PCIDs, βB and βC interact with βA preceding one of the helices in the WH region (Fig.  S3A) . Without βB and βC, atCSN1 H20-H21 cannot be held toward the same orientation as the ones in Rpn6 and atCSN7. Therefore, to rebuild the C-terminal end of atCSN1, we aligned Rpn6 α16 with atCSN1 H19 using the conserved residues in these helices (Fig. 2, Fig. S3B ) and grafted the rest of the Rpn6 C-terminal structure onto the atCSN1 structure to generate the tentative complete PCID of atCSN1 (Fig. S3C) . Interestingly, the intermolecular interactions at the H19-H21 region between chain A and chain B (Fig. S2B) and between chain C and symmetry-related chain D (Fig. S2D ) both mimic the intramolecular interaction in the modeled PCI domain, suggesting that the modeled H19-H21 structure cluster represents a conserved interaction in atCSN1 as well.
atCSN1 Interacts with atCSN7 (PCID) Through Its WH Subdomain. It was previously known that CSN1 and CSN7 interact with each other (32, 33) , and the interaction was quantified using isothermal titration calorimetry, yielding a K D of 2.2 ± 0.04 μM (34) . Given the available crystal structures of atCSN1 and atCSN7, we coexpressed atCSN1 and atCSN7 in E. coli and further investigated this interaction using the small-angle X-ray scattering (SAXS) method. The SAXS patterns of the atCSN1-atCSN7 binary complex in solution were recorded to generate the final composite scattering curves (Fig. 4A, Left) . By inspecting the Guinier plot of the complex, we saw an absence of protein aggregation and processed the data further. The gyration radius (R g ) of the complex is 32 Å whereas the maximum dimension (D max ) from the distance distribution function p(r) is 110 Å (Fig. 4A, Center) . The SAXS envelope of the atCSN1-atCSN7 binary complex reconstructed from the scattering patterns appears to be of a tubular shape with one large and one small section (Fig. 4A, Right) . The dimensions of the larger section are well consistent with the ones in our atCSN1 crystal structure, and the smaller section has similar dimensions as atCSN7 (PCID). It has been shown that the PCIDs of CSN1 and CSN7 are responsible for the mutual interaction (34) , which constrains the PCID of each of the proteins to be near the central part of the SAXS envelope. However, we do not know how the PCIDs should interact.
To facilitate fitting of the CSN1 and CSN7 structures into the envelope, we performed mutagenesis on CSN1. First, we constructed several recombinant atCSN1 C-terminal truncations for size-exclusion chromatography (SEC) comigration study (Fig.  4B) . As we anticipated, atCSN1 (16-400aa) with a complete PCID was capable of interacting with atCSN7 (PCID), and the binary complex comigrated on SEC (Fig. 4B, Left) . When we deleted the last two β-strands in the atCSN1 WH subdomain (16-380aa), the PCID-PCID interaction was affected but not eliminated (Fig. 4B, Center) . It was when we kept only H19 and removed everything else in the atCSN1 WH subdomain (16-349aa) that the interaction within the binary complex was completely abolished (Fig. 4B, Right) . These results indicate that residues from 350 to 400 of atCSN1 containing the C-terminal part of the WH domain of atCSN1 are essential for interaction with atCSN7. To further map which region of atCSN1 may directly mediate the interaction with atCSN7, we selected conserved residues from 350 to 400 and mutated those that are exposed or at least partly exposed to solvent (Figs. 2 and 4C ). We included conserved residues beyond our atCSN1 structure to assess their role, if any, in atCSN7 interaction. Most prominently, the F350A mutation almost completely abolished the interaction with atCSN7, and D387L greatly weakened the interaction. L373D also abolished the interaction with atCSN7, but the structural integrity of the mutant may have been compromised as suggested by the much lower expression level. In contrast, mutations M358Q, I377D, R385D, and N390A did not greatly reduce the interaction with atCSN7. The mutagenesis data provided a guide for fitting of CSN1. In addition, it has been shown previously that mutations K144A and E153A in atCSN7 did not affect the interaction with atCSN1 (34) ; the data were also used to guide fitting. The resulting structural model predicted an interaction in which helices and the in-between loops of the WH subdomains of atCSN1 and atCSN7 are in contact with each other (Fig. 4D) . The C-terminal β-strands of atCSN7 lie tangentially with the β-hairpin loop close to the interface. Such an orientation of the region may be taken by the C-terminal β-strands of atCSN1 as well in the structure with a complete PCID. The tangential location would explain the lack of strong effects when deleted in atCSN1; however, if a noncompatible mutation is introduced to a residue near the β-hairpin loop, such as D387L of atCSN1, interference with interaction could occur. Collectively, although the fitted model could not be atomically accurate, it provides a visual means for the possible mode of interaction between atCSN1 and atCSN7.
atCSN1 in the CSN-SCF Complex and the apo-CSN. CSN1 is known to play a crucial role in the integrity of the CSN complex (37, (39) (40) (41) . To identify functionally important regions in CSN1, we mapped the sequence similarity score onto the surface of the atCSN1 crystal structure (Fig. 5A) . Analysis shows that conserved areas lie at the surfaces of PCID and the LH and HR-II domains. A number of studies suggested that PCID mediates and stabilizes protein-protein interactions within the CSN complex (32) (33) (34) . We specifically show that atCSN1 residues 350-400, a segment within the WH subdomain, are essential for interaction with atCSN7 (Fig. 4B) . Our results, together with others mentioned, are consistent with the identified conserved PCID surface. In the EM structure of the CSN coupled with SCF, CSN1, CSN2, CSN3, CSN4, and CSN7 form an approximately coplanar structure through the PCIDs (38) . Based on this (34) were fitted into the SAXS envelope. The SAXS fitting shows that the two molecules most likely interact through the WH subdomains (dashed line area). F350 (red) of atCSN1 is at the interface with atCSN7. Residues whose mutations did not affect the atCSN1-atCSN7 mutual interaction, including K144 and E153 of atCSN7 (34) , are colored in cyan.
arrangement, it is possible that different surfaces of the atCSN1 PCID are responsible for interacting with the neighboring CSN subunits. However, a detailed understanding on how the PCIDs interact with each other in the CSN complex has to wait for a high-resolution CSN complex structure.
Interestingly, the EM structure of the CSN-SCF complex suggested that the N-terminal domains of CSN1 and CSN3 are connected with the substrate-recognition end of the SCF (38) . Therefore, we fitted the atCSN1 structure into this 25-Å EM map using the program Chimera (44) to determine how CSN1 may reside within the CSN-SCF complex (Fig. 5B) . The fitting generated a correlation coefficient, which indicates the agreement between the structure and the volume map, of 0.86. The overall position of the fitted atCSN1 crystal structure in the CSN-SCF complex is comparable with the one shown using predicted atomic model for CSN1-volume docking (38) , with the PCID of atCSN1 situating in some interior density of the CSN. Remarkably, the conserved regions in the LH and HR-II domains of atCSN1 are contacting the SCF substrate receptor according to our fitting (Fig. 5B) .
During the fitting process, we noticed a difference in the assigned CSN1-CSN7 volumes between the CSN-SCF EM map and the apo-CSN EM map (36, 38) . In the CSN-SCF EM map, CSN1 and CSN7 do not directly contact each other with a gap in the central arc region of the approximate coplanar arrangement (38) . However, in the apo-CSN EM map, this gap does not exist, with apparent continuous densities between CSN1 and CSN7. To confirm this observation, we docked our atCSN1-atCSN7 (PCID) SAXS envelope into the apo-CSN EM map. As predicted, the SAXS envelope aligned well with the assigned densities of the CSN1-CSN7 volume (Fig. 5C ). One possible explanation is that the CSN experiences subunit rearrangements upon association with SCF, a plasticity that is supported by several additional lines of evidence. First, in vitro, CSN7 can interact with either CSN1 or CSN8 to form binary complexes, but not simultaneously to form ternary complexes (34) . Second, in the apo-CSN, although CSN7 clearly interacts with CSN1, it barely touches CSN8 (36) . Third, in the CSN-SCF complex, CSN7 contacts neither CSN1 nor CSN8 (38) . Collectively, these data support conformational variability in the PCID interactions in the CSN.
atCSN1 Interacts with IκBα Through Its C-terminal Tail. So far, we have confirmed that the PCID of atCSN1 is important for PCID-PCID interactions whereas the HR-II and LH domains may occlude the substrate-recognition end of the SCF. The N-terminal half of CSN1 was reported to interact with Tonsoku-associating protein 1 (45) , SAP130/SF3b-3 (46), inositol 1,3,4-trisphosphate 5/6-kinase (17) , and ankyrin repeat and SOCS box-containing protein 4 (47) . Here, we report that the C-terminal tail beyond the PCID of H. sapiens CSN1 (hsCSN1), a segment not included in our crystal structure, interacts with IκBα in the NF-κB signaling pathway. We first made a c-Myc-tagged IκBα and various Flagtagged hsCSN constructs, hsCSN1-8 (full length) and hsCSN1 truncation mutants (1-461aa) and (1-362aa) . The proteins were in vitro translated one at a time in a cell-free environment. The translated sample containing expressed IκBα was incubated with each CSN-containing in vitro translated sample. After immunoprecipitation of Myc-IκBα from the different samples, interactions between the individual CSN subunit and IκBα were detected using an anti-Flag antibody (Fig. 6A, Fig. S4 ). Without the presence of other CSN subunits in the in vitro translation solutions, hsCSN1 interacted with IκBα through residues 461-527. According to secondary structure prediction, this region contains an ∼20-aa α-helix followed by some disordered segments. The C-terminal tail of hsCSN1 is most likely flexible as we do not visualize extra density around the CSN1 (PCID) region in either the CSN or the CSN-SCF EM map. The flexible tail is then possibly exposed for interaction with IκBα in the context of the full CSN (Fig. 6B) . The only other subunit that interacted with (1-461aa), hsCSN (1-362aa), and hsCSN4 (full length), were constructed. Lane 3 shows that CSN1 interacts with IκBα through residues 461-527. (B) The flexible tail of CSN1 is possibly exposed for interaction with IκBα in the context of the full CSN. atCSN1 in the EM map of the CSN-SCF complex, and the arrow indicates the C-terminal end of our atCSN1 structure. (C) CSN complex in NF-κB pathways. One, CSN complex influences protein stability by removing Nedd8 from cullin-RING-E3 ligase (9, 14) . Two, CSN complex can inhibit a catalytically competent SCF by binding both substrate receptor and Rbx1-Cul1 C-terminal domain of SCF complex (38) . Three, CSN complex is known to interact with deubiquitylation enzymes USP15 to suppress NF-κB activation (12, 22) . Four, the C-terminal tail of CSN1 interacts with IκBα with current unknown mechanism. IB, immunoblotting; IP, immunoprecipitation. IκBα is CSN3 (Fig. S4) , suggesting that the adjacently located CSN1 and CSN3 cooperate to recruit IκBα. In NF-κB pathways, as one example, the CSN complex acts as a platform arranging protein communications (Fig. 6C) . Upon stimulations, IκBα is phosphorylated by the IκB kinase (IKK) (48) , which is then recognized by the substrate receptor of the SCF for polyubiquitination, leading to subsequent proteasomal degradation. Degradation of IκBα releases NF-κB for nuclear translocation and activation of transcription. Four, or more, direct interactions between the CSN and the players within the pathway may lead to regulation of NF-κB activities. One, by removing Nedd8 from the SCF E3 ligase, the CSN complex impoverishes the assembly and ubiquitination activity of the SCF complex (49, 50) . Thus, deneddylation here leads to NF-κB inactivation. Two, the CSN complex can also inhibit a catalytically competent SCF by directly interacting with both substrate receptor and Rbx1-Cul1 Cterminal domain of the SCF complex (38) . Three, the CSN complex is known to interact with the deubiquitination enzyme USP15 to suppress NF-κB activation (12, 22) . Four, we show that the C-terminal tail of CSN1 interacts with IκBα, possibly bringing IκBα to CSN-recruited USP15 for deubiquitination. Such a recruiting mechanism may be facilitated by the neighboring CSN3 because we learned that IκBα directly interacts with either CSN1 or CSN3 (Fig. S4) . Overall, the CSN complex uses multiple mechanisms to hinder NF-κB activation, a principle likely to hold true for its regulation of many other targets and pathways.
Materials and Methods
atCSN1 was expressed in E. coli BL21 (DE3). All proteins were purified using Ni-affinity chromatography followed by anion-exchange chromatography (Uno-Q) and SEC ). atCSN1 (16-400aa ) was crystallized at 20°C in 0.1 M Bis-tris propane, pH 7.0, 0.2 M ammonium sulfate, 10% (wt/ vol) polyethylene glycol 8000, and 5 mM DTT. The structure was determined by the multi-wavelength anomalous diffraction (MAD) method using a [Ta 6 Br 12 ] 2+ soaked crystal.
For detailed experimental procedures, please see SI Materials and Methods.
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